반응 #3129

ord-76f66933b8914bb1a7437f5254a0de57

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    추출The target substance was extracted from the mixture by ethyl acetate
  2. 2
    세척The extract was washed with saturated sodium chloride solution
  3. 3
    건조was dried over anhydrous sodium sulfate
  4. 4
    농축This solution was concentrated under reduced pressure
  5. 5
    기타was purified by a preparative TLC (Merck TLC plate silica gel 60 F254, 20×20 cm, layer thickness 0.25 mm, 2 pieces, ethyl acetate:hexane 4:1)

실험 절차

A hydrogen fluoride-pyridine solution (0.1 ml) was added to a solution of ice-cooled acetonitrile (1 ml) and pyridine (0.1 ml), then a pyridine (0.1 ml) solution of (11R,12S,13E,15S)-9-butyryloxy-11,15-bis(tert-butyldimethylsiloxy)-7-thiaprosta-8,13-dienoic acid (79 mg) was added. The ice bath was detached, then the solution was stirred for 20 hours while raising it to room temperature. The reaction solution was poured into a mixture of ethyl acetate and saturated sodium hydrogencarbonate. The target substance was extracted from the mixture by ethyl acetate. The extract was washed with saturated sodium chloride solution, then was dried over anhydrous sodium sulfate. This solution was concentrated under reduced pressure, then was purified by a preparative TLC (Merck TLC plate silica gel 60 F254, 20×20 cm, layer thickness 0.25 mm, 2 pieces, ethyl acetate:hexane 4:1) to obtain (11R,12S,13E,15S)-9-butyryloxy-11,15-dihydroxy-7-thiaprosta-8,13-diene acid (17 mg, 33%).

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US05731452uspto-grants-1998_03